文献速递胸部肿瘤放疗

单核苷酸变异rs2868371与非小细胞肺癌患者死亡风险的关联:一项多中心前瞻性验证研究

The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation.
PubMed 文献 · Radiother Oncol · 2019-04-06

该多中心前瞻性研究在181例欧洲非小细胞肺癌患者中验证HSPB1基因SNP rs2868371与生存的关联,中位随访13个月。多因素分析显示rs2868371 GG基因型与更好的总生存相关(HR 0.35,95%CI 0.13-0.96,p=0.042),2年总生存率GG组72% vs CC/CG组36%(p=0.013),GG型也与更好的无病生存相关(HR 0.36,95%CI 0.13-0.99,p=0.048)。

要点

  • rs2868371 GG基因型与非小细胞肺癌患者更好的总生存相关(HR 0.35,95%CI 0.13-0.96,p=0.042)。
  • 2年总生存率GG基因型患者72% vs CC/CG基因型患者36%(p=0.013)。
  • rs2868371 GG基因型与更好的无病生存相关(HR 0.36,95%CI 0.13-0.99,p=0.048)。

核心结论

  • 功能性HSPB1 rs2868371启动子变异可能通过糖皮质激素受体相互作用调控HSPB1表达水平,从而影响肺癌生存。

研究设计与样本

  • 多中心前瞻性验证研究,纳入欧洲队列181例非小细胞肺癌患者,中位随访时间13个月(范围3-57个月)。

主要发现

  • 多因素分析显示rs2868371 GG基因型与更好的总生存相关(HR 0.35,95%CI 0.13-0.96,p=0.042)。
  • rs2868371 GG基因型患者2年总生存率为72%,CC/CG基因型患者为36%(p=0.013)。
  • 多因素分析显示rs2868371 GG基因型与更好的无病生存相关(HR 0.36,95%CI 0.13-0.99,p=0.048)。
  • 计算机分析提示替代等位变异间糖皮质激素受体结合位点亲和力存在显著差异,染色质免疫沉淀分析证实风险等位基因C亲和力更强。
  • 研究提示rs2868371影响HSPB1 mRNA表达,为HSPB1转录调控提供见解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Definitive radiation therapy (RT) with or without chemotherapy has become the standard treatment for non-metastatic unresectable non-small cell lung cancer (NSCLC). However, treatment outcomes can differ substantially and patients' genetic background could play a crucial role. Potential associations between single-nucleotide polymorphisms (SNP) in Heat shock protein beta-1 (HSPB1) and survival have been reported in prior single-institution retrospective reports. MATERIALS AND METHODS: The current assay aims to validate such connection in a prospective multicenter study in a European cohort including 181 NSCLC patients. Median follow-up time for all patients was 13 months (range, 3-57 months). RESULTS: The results obtained show an association between the rs2868371 GG genotype and better overall survival (HR: 0.35; 95%CI: 0.13-0.96; p = 0.042) in multivariate analysis. Two-year overall survival rate was 72% for patients carrying the rs2868371 GG genotype versus 36% for those patients harboring the rs2868371 CC/CG genotypes (p = 0.013). Additionally, the rs2868371 GG genotype was found to be associated with better disease-free survival in the multivariate analysis (HR: 0.36; 95%CI: 0.13-0.99; p = 0.048). In silico analysis of the potential functional SNP suggested significant difference in the affinity of the Glucocorticoid Receptor binding site between alternative allelic variants, confirmed by chromatin immunoprecipitation analysis displaying stronger affinity for the risk allele (C). Furthermore, our findings indicate that the rs2868371 influences (mRNA) HSPB1 expression, offering insight into the regulation of HSPB1 transcription. CONCLUSION: The functional HSPB1 rs2868371 promoter variant may affect lung cancer survival by regulation of HSPB1 expression levels through glucocorticoid receptor interaction.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Enguix-Riego MDV, Cacicedo J, Delgado León BD, et al. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation. Radiother Oncol. 2019. PMID: 31015126. doi:10.1016/j.radonc.2019.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。